Get Healthy!

  • Posted October 29, 2024

Semaglutide Helps Prevent Kidney Damage in People with Obesity

A new study finds semaglutide, the active ingredient in Ozempic and Wegovy, reduced kidney damage by up to 52% in people with obesity.

Health News is provided as a service to A&S Drugs site users by HealthDay. A&S Drugs nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.
Copyright © 2024 HealthDay All Rights Reserved.

Share

Tags